Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
70.60
+1.06 (1.52%)
At close: Jan 23, 2026
Hangzhou Alltest Biotech Revenue
Hangzhou Alltest Biotech had revenue of 203.23M CNY in the quarter ending September 30, 2025, a decrease of -8.26%. This brings the company's revenue in the last twelve months to 881.63M, up 8.47% year-over-year. In the year 2024, Hangzhou Alltest Biotech had annual revenue of 866.58M with 14.83% growth.
Revenue (ttm)
881.63M
Revenue Growth
+8.47%
P/S Ratio
6.27
Revenue / Employee
909.84K
Employees
969
Market Cap
5.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 866.58M | 111.89M | 14.83% |
| Dec 31, 2023 | 754.70M | -2.63B | -77.73% |
| Dec 31, 2022 | 3.39B | 1.52B | 80.88% |
| Dec 31, 2021 | 1.87B | 737.87M | 64.98% |
| Dec 31, 2020 | 1.14B | 894.22M | 370.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Blue Sail Medical | 5.78B |
| Zhonghong Pulin Medical Products | 2.48B |
| Well Lead Medical | 1.64B |
| Jiangxi Sanxin Medtec | 1.59B |
| Zhejiang Gongdong Medical Technology | 1.12B |
| Aidite (Qinhuangdao) Technology | 993.58M |
| SWS Hemodialysis Care | 733.59M |
| Chimin Health Management | 637.78M |